Jun 9, 2023 04:01PM

Jun 7, 2023 05:17AM

Jun 6, 2023 11:25PM

Apr 24, 2023 08:00AM

Apr 3, 2023 08:09AM

Apr 3, 2023 08:00AM

Mar 31, 2023 08:00AM NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update

Mar 1, 2023 08:00AM

Feb 9, 2023 08:00AM

Feb 6, 2023 08:08AM

Feb 6, 2023 08:00AM

Jan 17, 2023 08:00AM

Nov 23, 2022 08:03AM

Nov 23, 2022 08:00AM NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential

27,736 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All